Dr. Peter Oppelt, M.D.
Claim this profileWashington University School of Medicine
Area of expertise
Squamous Cell Carcinoma
Peter Oppelt, M.D. has run 9 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Head And Neck Squamous Cell Carcinoma
Peter Oppelt, M.D. has run 7 trials for Head and Neck Squamous Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Washington University School Of Medicine
Clinical Trials Peter Oppelt, M.D. is currently running
Registry
for Peripheral Nerve Sheath Tumor
First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor lesions (e.g., atypical or nodular plexiform neurofibromas). A worldwide database will be established, collecting, in a standardized manner, histologic, immunohistochemical, molecular, radiographic, treatment, and related clinical data from centers worldwide with expertise in these NF1-related cancers. Although retrospective in nature, the resulting data from this registry may reveal previously unanticipated patterns, similar to the INFACT effort outcome. This registry would then allow the acquisition of data associated with MPNST biospecimens collected under associated banks (frozen or paraffin-embedded, germline (or normal tissue DNA) samples, and any previously somatic whole-exome or whole-genome sequencing data for aggregate analyses). Second, the investigators plan to co-register patients to institutional banks in order to prospectively collect MPNST samples for analysis. These patients will be consented in order to collect the above information and for banking of tumor tissue and future studies that include genomic characterization of the tumors.
Recruiting
1 award
N/A
1 criteria
Ramucirumab + Pembrolizumab
for Head and Neck Cancer
This is a phase 2 study investigating the efficacy of ramucirumab in combination with pembrolizumab compared to pembrolizumab monotherapy. Ramucirumab is a VEGFR-2 inhibitor believed to potentially enhance the efficacy of PD-1 inhibitors such as pembrolizumab.
Recruiting
1 award
Phase 2
17 criteria
More about Peter Oppelt, M.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Peter Oppelt, M.D. has experience with
- Pembrolizumab
- Nivolumab
- Atezolizumab
- Ramucirumab
- Carboplatin
- Cisplatin
Breakdown of trials Peter Oppelt, M.D. has run
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Oppelt, M.D. specialize in?
Peter Oppelt, M.D. focuses on Squamous Cell Carcinoma and Head and Neck Squamous Cell Carcinoma. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are p16 positive.
Is Peter Oppelt, M.D. currently recruiting for clinical trials?
Yes, Peter Oppelt, M.D. is currently recruiting for 8 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Peter Oppelt, M.D. has studied deeply?
Yes, Peter Oppelt, M.D. has studied treatments such as Pembrolizumab, Nivolumab, Atezolizumab.
What is the best way to schedule an appointment with Peter Oppelt, M.D.?
Apply for one of the trials that Peter Oppelt, M.D. is conducting.
What is the office address of Peter Oppelt, M.D.?
The office of Peter Oppelt, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63119 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.